Abstract
This research service covers the Latin America Cardiovascular drugs market
from 2004 to 2011, with 2006 as the base year. Major markets were studied:
Brazil and the Andean Region (which includes Colombia and Venezuela, countries
that are estimated to achieve double digit growth rates in the forecast
period).
|